Warning letter
Bedfont Scientific, Ltd.: warning letter of Feb 12, 2020
FDA warning letter 604311 · Center for Devices and Radiological Health
Key facts
| Reference number | 604311 |
|---|---|
| Company | Bedfont Scientific, Ltd. |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Feb 12, 2020 |
| Posted date | May 5, 2020 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 820 |
| Inspection city | Maidstone |
| Inspection start date | Oct 28, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: